Salarius Pharmaceuticals Surges By 31%: Unpacking the Market Trends

In a whirlwind of trading activity today, the stock of Salarius Pharmaceuticals, Inc. SLRX skyrocketed, fueled by the unveiling of the company’s fourth-quarter financial performance.

The latest earnings report divulged a net loss of $0.9 million, translating to 22 cents per share for the final quarter, a substantial improvement compared to the previous year’s $6.4 million loss, equating to $2.83 per share, as per data from Benzinga Pro.

Following this financial showcase, Salarius Pharmaceuticals witnessed a significant surge of 31.4%, with its share price catapulting to $0.8149 in pre-market trading.

As the spotlight shines on Salarius Pharmaceuticals, there’s a ripple effect across the pre-market session, showcasing several other stocks making notable moves.

Positive Market Momentum

• Next.e.GO N.V. EGOX witnessed a remarkable surge of 85.8% to $0.0730 during pre-market trading, rebounding from a 22% fall on the preceding Friday.
• MicroAlgo Inc. MLGO experienced a substantial upswing of 56.7% to $6.30 in pre-market trading, following a 5% decline on Friday.
• Forge Global Holdings, Inc. FRGE climbed 22.8% to $2.86 in pre-market trading after a 13% gain on Friday.
• Canopy Growth Corporation CGC surged 19.5% to $9.17 in pre-market trading, buoyed by the German government’s approval of cannabis-related legislation, effective April 1.
• Flora Growth Corp. FLGC enjoyed a 17.7% hike to $1.86 during pre-market trading, following a significant 34% leap on Friday.
• Cazoo Group Ltd CZOO surged 17.3% to $4.35 in pre-market trading after a 21% decline on Friday.
• Biophytis S.A. BPTS jumped 17.1% to $0.4471 in pre-market trading after presenting the Phase 3 protocol of RuvembriTM for Sarcopenia treatment at the ICFSR.
• Recon Technology, Ltd. RCON witnessed a 14.5% surge to $0.1570 in pre-market trading.
• Esperion Therapeutics, Inc. ESPR rose 12.7% to $2.58 in pre-market trading following the U.S. FDA’s approval of expanded labels for NEXLETOL® and NEXLIZET® for cardiovascular prevention.

Negative Market Trends

• Sintx Technologies, Inc. SINT plummeted by 29.7% to $0.0650 in pre-market trading post a 32% dip on Friday, driven by a proposed common stock offering.
• Invivyd, Inc. IVVD declined by 14.8% to $3.72 in pre-market trading following a 41% surge on Friday, fueled by PEMGARDA’s FDA emergency use authorization for COVID-19 prophylaxis.
• Greenlane Holdings, Inc. GNLN dropped 10.8% to $0.52 in pre-market trading after an 11% rise on Friday.
• BYND Cannasoft Enterprises Inc. BCAN fell 10.8% to $2.24 in pre-market trading following a 31% decline on Friday.
• Mangoceuticals, Inc. MGRX witnessed a downturn of 9.7% to $0.1688 in pre-market trading after a 5% decline on Friday.
• Australian Oilseeds Holdings Limited COOT declined by 8.5% to $2.27 in pre-market trading post a over 22% fall on Friday.
• Ontrak, Inc. OTRK fell 8.2% to $0.36 in pre-market trading post a 50% surge on Friday.
• Murano Global Investments Plc MRNO dropped 7.6% to $19.64 in pre-market trading amid uncertainties following the recent business combination with HCM Acquisition Corp and Nasdaq debut.
• Laser Photonics Corporation LASE witnessed a 6.5% decline to $1.73 in pre-market trading after a 9% dip on Friday post announcing a distribution deal with Incredible Supply & Logistics (ISL) for military and industrial laser solutions.
• OKYO Pharma Limited OKYO tumbled 6.2% to $1.44 after falling around 13% on Friday, post releasing additional clinical data on OK-101 (0.05%) for dry eye disease treatment.

 

Get a sneak peek at the Top 5 Consumer Stocks That May Crash This Month